New drug shows promise for reducing narcolepsy attacks over the long term
NCT ID NCT05113745
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at the long-term safety and effectiveness of a drug called AXS-12 for people with narcolepsy who also have sudden muscle weakness (cataplexy) and severe daytime sleepiness. 68 people who had already completed an earlier study took AXS-12 and were monitored for side effects and changes in how often they had cataplexy attacks. The goal was to see if the drug remains safe and helpful over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CATAPLEXY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Site
Phoenix, Arizona, 85054, United States
-
Clinical Research Site
Boulder, Colorado, 80301, United States
-
Clinical Research Site
Colorado Springs, Colorado, 80918, United States
-
Clinical Research Site
Brandon, Florida, 33511, United States
-
Clinical Research Site
Clearwater, Florida, 33765, United States
-
Clinical Research Site
Doral, Florida, 33122, United States
-
Clinical Research Site
Miami Lakes, Florida, 33016, United States
-
Clinical Research Site
Winter Park, Florida, 32789, United States
-
Clinical Research Site
Atlanta, Georgia, 30315, United States
-
Clinical Research Site
Atlanta, Georgia, 30328, United States
-
Clinical Research Site
Stockbridge, Georgia, 30281, United States
-
Clinical Research Site
Chevy Chase, Maryland, 20815, United States
-
Clinical Research Site
Kalamazoo, Michigan, 49008, United States
-
Clinical Research Site
Novi, Michigan, 48377, United States
-
Clinical Research Site
Neptune City, New Jersey, 07753, United States
-
Clinical Research Site
Denver, North Carolina, 28037, United States
-
Clinical Research Site
Gastonia, North Carolina, 28054, United States
-
Clinical Research Site
Huntersville, North Carolina, 28078, United States
-
Clinical Research Site
Cincinnati, Ohio, 45245, United States
-
Clinical Research Site
Wyomissing, Pennsylvania, 19610, United States
-
Clinical Research Site
Charleston, South Carolina, 29425, United States
-
Clinical Research Site
Columbia, South Carolina, 29201, United States
-
Clinical Research Site
Austin, Texas, 78731, United States
-
Clinical Research Site
San Antonio, Texas, 78229, United States
-
Clinical Research Site
Toronto, Ontario, M5S 3A3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do current sleepiness tests work for kids? a new study puts them to the test
- New test could sharpen diagnosis of narcolepsy and related sleep disorders
- New pill aims to tame Narcolepsy's sleep attacks and sudden muscle weakness
- Dream control: a new behavioral approach to tame narcolepsy nightmares
- Pregnancy safety of narcolepsy drug pitolisant under scrutiny
- New drug shows promise for Narcolepsy's worst symptoms